Navigation Links
Dr. Will Sawyer and Henry the Hand Champion Handwasher Have Discovered How to PREVENT the Flu and Common Cold!! DO NOT TOUCH the T Zone!
Date:12/2/2008

CINCINNATI, Dec. 2 /PRNewswire-USNewswire/ -- What is the T Zone? It is the mucous membranes of your eyes, nose or mouth. Touching your mucous membranes is how most germs enter your body and grow to make you sick. Touching the T Zone is also referred to as direct inoculation or contamination, eye rubbing, nose picking, nail biting and many other descriptors. By simply increasing public awareness about this habit you will help reduce flu and flu-like illness this winter. It is also one of the Principles of Hand Awareness endorsed by the AMA and AAFP.

The 4 Principles of Hand Awareness include:

  1. Wash your hands before you eat and when they are dirty.
  2. Do not cough into your hands.
  3. Do not sneeze into your hands.
  4. Do not put your finger into your eyes, nose or mouth.

Did you know 164,000,000 days are lost from school due to illness, of which 22,000,000 are due to the common cold alone? Imagine not being sick this winter! Infection prevention starts with you and your Hands. Hands are the vector that transmit a majority of the germs causing respiratory and gastro-intestinal illnesses. It is not forgetting our hat or going out in the rain that causes us to become ill. We humans are the petri dish that grow and spread these diseases. Help break this chain reaction of disease by "speaking up" when someone touches the T Zone. Lend a Hand to your friends, family and fellow employees in meetings to "stand up" if they touch the T zone (breaching their mucous membranes), as a friendly reminder. No one chooses to be ill; it is an "unconscious" behavior that causes it!

Help keep your family, friends and fellow employees healthy this winter! Nothing stops the spread of sickness like simple hand washing, according to Dr. Will Sawyer founder of the Henry the Hand foundation. "Hand awareness a
'/>"/>

SOURCE Henry the Hand Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Henry H. Kessler Foundation Rebranded as Kessler Foundation
2. Henry Mayo Newhall Memorial Hospital to Proceed With Master Plan
3. Henry C. Windell, DMD, Elected to Board of Trustees of the American Association of Oral and Maxillofacial Surgeons
4. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
5. The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary
6. Jack Henry & Associates Divests Insurance Agency Outsourcing Business Line
7. Stella Mora Henry to Present The Eldercare Handbook at Aging in America Joint Conference of National Council on Aging & The American Society on Aging March 27-29
8. Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
9. Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
10. Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems MicroMD(R) EMR 5.0
11. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 3D animation detailing plastic s... Elements website. Surgical candidates can view pr...ctly from the page. , (PR...ine compression garments retailer, has always been...ery patients after their procedures, providing lip...
(Date:12/2/2009)... myEMRchoice.com Enables Personal... Fort Washington, PA (PRWEB) Dec...o give consumers is to read their own medical reco...), keeping control of personal medical records is ...on, PA based healthcare technology company has add...
(Date:12/2/2009)... Award-winning author James A. Fe...th book, Short White Coat: Lessons from Patients o...ough the third year of medical school--the gruelin...ELPHIA, PA (PRWEB) December 2, 2009 -- Most peopl...selves dressed in a tiny hospital gown or staring ...
(Date:12/2/2009)... Leading medical device software ... has received ISO 13485 certification. A relativel...ng firms have actually achieved ISO 13485 certific...ertification and adhere to other ISO standards as ...evice software engineering consulting firm to achi...
(Date:12/2/2009)..., SAN DIEGO, Dec. 2 G...t at the 21st Annual Piper Jaffray Health Care Con...ntation is scheduled to be webcast live and may be...of Gen-Probe,s website at www.gen-probe.com . The...he event. ,, About Gen-Probe ,, Gen-Probe...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2
...ments for what doctors say is a life-threatening m...hDay News) -- Sen. Edward M. Kennedy enjoyed "a re...of Duke University Medical Center on Tuesday, one ...y was "recuperating well from yesterday,s procedur...
... to be more clear in explaining realities , ...ons not easily understood, many patients with the ...onger than their doctors tell them they will, new ...lity to pump blood -- that the condition would sho...
...nown origin, rheumatoid arthritis (RA) affects abo... destruction, RA often leads to disability and dim...arly death from cancer. Various studies have link...modifying antirheumatic drug (DMARD) commonly pres...
... Underwriters- -Offers Specialized Coverage fo..., June 3 The Hanover,Insurance Group, Inc. (NYSE:...ualty company, today announced it has extended the...ia. The program,offers specialized protection to m...
...ployee,Benefit Research Institute (EBRI) today pub...of the amount of money individuals and couples wil...tirement. The new estimates,attempt to provide mor...f medical care coverage available when they,reach ...
... pancreatic and spinal cancer, SHERWOOD, Ore., Ju...a quiet life at Avamere at,Sherwood in Oregon. The...ngs and frequent visits from his daughter Yolanda ...g cruises for,celebrities. In 1977, he finished Ey...
Other Medicine News:Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 2Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 3Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 4Health News:Heart Failure Patients Overestimate Their Life Expectancy 2Health News:Heart Failure Patients Overestimate Their Life Expectancy 3Health News:Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate 2Health News:Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate 3Health News:The Hanover Extends Schools Program, Making the Grade in GA, KS, MD, and VA 2Health News:The Hanover Extends Schools Program, Making the Grade in GA, KS, MD, and VA 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 2Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 4Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 5Health News:Sherwood, Oregon Sailor, 78, Goes on Final Voyage 2
(Date:12/1/2009)...., Dec. 1 CeloNova BioSciences, In... medical devices and of specialty implants, today ..., founder and medical director of Baptist Cardiac ...iscuss the CATANIA(TM) Stent System with NanoThin ...lar Interventions Conference to be held at the Hot...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
(Date:12/1/2009)...., Dec. 1 SCOLR Pharma, ... 20, 2009 it licensed to Chrono Nutraceuticals LLC...l four extended release dietary supplements using ...rm. In addition, SCOLR granted Chrono rights to m...ited States on a nonexclusive basis. Chrono paid ...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3American Nurses Association Joins the National Healthcare Career Network 54285 1American Nurses Association Joins the National Healthcare Career Network 54285 2American Nurses Association Joins the National Healthcare Career Network 54285 3Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 1Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 2Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 3The tourist trap 9540 1
...ial New Front-Line Treatment ...Genzyme Corp.,(Nasdaq: GENZ ) reported preliminar...2 study examining the safety and effectiveness of ...ously untreated, older adult,patients with acute m...fit,from conventional "7+3" anthracycline plus cyt...
...CALS, INC. (Nasdaq: VION ) today announced that i... lead anticancer agent Cloretazine(R),(VNP40101M) ...yelogenous,leukemia (AML) had been presented at th...linical Oncology (ASCO(R)) in Chicago, Illinois., ...atients. The median,age of these patients was 73 y...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 4
...t-Cath, Maximum, Maximum Xtra™, and Maximum ...of standard and specialty hemostasis introducers i...mostasis introducers for use in interventional car... angiography, angioplasty, stenting, atherectomy, ...
Lumenis 950 Slit Lamp
Selecta Duo Photocoagulator Combination Laser
Apeel™ CS Catheter Delivery System
Medicine Products: